• Complex
  • Title
  • Keyword
  • Abstract
  • Scholars
  • Journal
  • ISSN
  • Conference
成果搜索

author:

Cheng, Cui (Cheng, Cui.) [1] (Scholars:程翠) | Zhang, Zhihong (Zhang, Zhihong.) [2] | Wang, Siyuan (Wang, Siyuan.) [3] | Chen, Li (Chen, Li.) [4] (Scholars:陈立) | Liu, Qinying (Liu, Qinying.) [5]

Indexed by:

EI Scopus SCIE

Abstract:

miRNAs such as miR-148b play crucial regulatory role in tumor metastasis, but their applications are limited because they are easy to degrade in serum conditions and lack targeting ability. Herein, CC9-PEG-SSBPEI was synthesized and used as nano-carrier for miR-148b. DLS and gel retardation analyses indicated that CC9-PEG-SSBPEI could combine with miR-148b by charge interaction and formed into nanoparticles with the size changed from 811.6 nm to 146.4 nm. CC9-PEG-SSBPEI could protect miR-148b from RNase A degradation and showed a reduction sensitive release of miR-148b. FACS analysis and CLSM images displayed that the conjugated CC9 peptide improved the accumulation and penetration of the nanoparticles in HuH-7 liver cancer cells through binding with the target of miR-148b neuropilin-1(NRP-1) on the cell surface. The raised level of miR-148b in turn inhibited the expression of NRP-1 and suppressed the migration of HuH-7 liver cancer cells. Moreover, hemolysis and cytotoxicity assay demonstrated that the nanoparticles had good hemo- and cyto-compatibility. Hence, CC9-PEG-SSBPEI/miR-148b nanoparticles had the potential for targeting delivery of miR-148b and anti-metastasis of hepatocellular carcinoma (HCC) cells.

Keyword:

CC9 peptide miR-148b Nanoparticles Reduction sensitive Targeting delivery

Community:

  • [ 1 ] [Cheng, Cui]Fuzhou Univ, Inst Biomed & Pharmaceut Technol, Fuzhou 350002, Fujian, Peoples R China
  • [ 2 ] [Zhang, Zhihong]Fuzhou Univ, Inst Biomed & Pharmaceut Technol, Fuzhou 350002, Fujian, Peoples R China
  • [ 3 ] [Wang, Siyuan]Fuzhou Univ, Inst Biomed & Pharmaceut Technol, Fuzhou 350002, Fujian, Peoples R China
  • [ 4 ] [Chen, Li]Fuzhou Univ, Inst Biomed & Pharmaceut Technol, Fuzhou 350002, Fujian, Peoples R China
  • [ 5 ] [Liu, Qinying]Fujian Canc Hosp, Fujian Prov Key Lab Tumor Biotherapy, Fuzhou 350014, Fujian, Peoples R China
  • [ 6 ] [Liu, Qinying]Fujian Med Univ, Canc Hosp, Fuzhou 350014, Fujian, Peoples R China

Reprint 's Address:

  • 陈立

    [Chen, Li]Fuzhou Univ, Inst Biomed & Pharmaceut Technol, Fuzhou 350002, Fujian, Peoples R China;;[Liu, Qinying]Fujian Canc Hosp, Fujian Prov Key Lab Tumor Biotherapy, Fuzhou 350014, Fujian, Peoples R China;;[Liu, Qinying]Fujian Med Univ, Canc Hosp, Fuzhou 350014, Fujian, Peoples R China

Show more details

Related Keywords:

Source :

COLLOIDS AND SURFACES B-BIOINTERFACES

ISSN: 0927-7765

Year: 2019

Volume: 183

4 . 3 8 9

JCR@2019

5 . 4 0 0

JCR@2023

ESI Discipline: BIOLOGY & BIOCHEMISTRY;

ESI HC Threshold:189

JCR Journal Grade:1

CAS Journal Grade:2

Cited Count:

WoS CC Cited Count: 6

SCOPUS Cited Count: 7

ESI Highly Cited Papers on the List: 0 Unfold All

WanFang Cited Count:

Chinese Cited Count:

30 Days PV: 0

Online/Total:71/10116495
Address:FZU Library(No.2 Xuyuan Road, Fuzhou, Fujian, PRC Post Code:350116) Contact Us:0591-22865326
Copyright:FZU Library Technical Support:Beijing Aegean Software Co., Ltd. 闽ICP备05005463号-1